Regulatory T cells in systemic lupus erythematosus

European Journal of Immunology

Volumn 45, Issue 2, 2015, Pages 344-355

  Ohl, Kim ^a   Tenbrock, Klaus ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

FoxP3; Helios; Regulatory T cell subsets; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; CD161 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IKAROS TRANSCRIPTION FACTOR; IKZF2 PROTEIN, HUMAN;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PATHOLOGY; PROCEDURES;

ANIMALS; AUTOIMMUNITY; BIOMARKERS; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IKAROS TRANSCRIPTION FACTOR; IMMUNE TOLERANCE; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 84923117239     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344280     Document Type: Article

References (122)

1. Tsokos, G. C., Systemic lupus erythematosus. N. Engl. J. Med. 2011. 365: 2110-2121.
2. Scheinecker, C., Bonelli, M. and Smolen, J. S., Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J. Autoimmun. 2010. 35: 269-275.
3. Crispin, J. C., Kyttaris, V. C., Terhorst, C. and Tsokos, G. C., T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 2010. 6: 317-325.
4. Shevach, E. M., Regulatory T cells in autoimmmunity*. Annu. Rev. Immunol. 2000. 18: 423-449.
5. Scalapino, K. J., Tang, Q., Bluestone, J. A., Bonyhadi, M. L. and Daikh, D. I., Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 2006. 177: 1451-1459.
6. + regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice. Arthritis Res. Ther. 2013. 15: R35.
7. Humrich, J. Y., Morbach, H., Undeutsch, R., Enghard, P., Rosenberger, S., Weigert, O., Kloke, L. et al., Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus. Proc. Natl. Acad. Sci. USA 2010. 107: 204-209.
8. + T cells expressing the FoxP3 transcription factor. Immunity 2009. 30: 899-911.
9. + T cells capable of producing proinflammatory cytokines. Blood 2013. 121: 2647-2658.
10. + follicular regulatory T cells control the germinal center response. Nat. Med. 2011. 17: 975-982.
11. + T regulatory cells. J. Immunol. 2010. 184: 3433-3441.
12. Golding, A., Hasni, S., Illei, G. and Shevach, E. M., The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus. Arthritis Rheum. 2013. 65: 2898-2906.
13. + regulatory T cells are expanded in active systemic lupus erythematosus. Ann. Rheum. Dis. 2013. 72: 1549-1558.
14. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W. et al., Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2000. 192: 303-310.
15. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
16. + T-cell effector differentiation by modulating IL-2 homeostasis. Proc. Natl. Acad. Sci. USA 2011. 108: 7529-7534.
17. + regulatory T cells. J. Immunol. 2005. 175: 4180-4183.
18. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007. 110: 2983-2990.
19. Lal, G. and Bromberg, J. S., Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009. 114: 3727-3735.
20. Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K. et al., Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007. 5: e38.
21. Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grutzkau, A., Dong, J., Thiel, A. et al., DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007. 37: 2378-2389.
22. Kim, H. P. and Leonard, W. J., CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 2007. 204: 1543-1551.
23. + regulatory T cells. Nat. Rev. Immunol. 2011. 11: 119-130.
24. + T regulatory cells. Nat. Immunol. 2003. 4: 337-342.
25. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E. et al., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001. 27: 68-73.
26. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E. et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001. 27: 20-21.
27. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E. et al., X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001. 27: 18-20.
28. Pesenacker, A. M., Broady, R. and Levings, M. K., Control of tissue-localized immune responses by human regulatory T cells. Eur. J. Immunol. 2014. 45: 333-343.
29. Bluestone, J. A. and Abbas, A. K., Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003. 3: 253-257.
30. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
31. + regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
32. Setoguchi, R., Hori, S., Takahashi, T. and Sakaguchi, S., Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 2005. 201: 723-735.
33. Liao, W., Lin, J. X. and Leonard, W. J., IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 2011. 23: 598-604.
34. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006. 108: 1571-1579.
35. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C. and Horak, I., Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993. 75: 253-261.
36. Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. and Alt, F. W., Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995. 3: 521-530.
37. Brandenburg, S., Takahashi, T., de la Rosa, M., Janke, M., Karsten, G., Muzzulini, T., Orinska, Z. et al., IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells. Eur. J. Immunol. 2008. 38: 1643-1653.
38. Barron, L., Dooms, H., Hoyer, K. K., Kuswanto, W., Hofmann, J., O'Gorman, W. E. and Abbas, A. K., Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J. Immunol. 2010. 185: 6426-6430.
39. Perry, D., Sang, A., Yin, Y., Zheng, Y. Y. and Morel, L., Murine models of systemic lupus erythematosus. J. Biomed. Biotechnol. 2011. 2011: 271694.
40. Rottman, J. B. and Willis, C. R., Mouse models of systemic lupus erythematosus reveal a complex pathogenesis. Vet. Pathol. 2010. 47: 664-676.
41. + T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus 2004. 13: 192-200.
42. Yang, C. H., Tian, L., Ling, G. S., Trendell-Smith, N. J., Ma, L., Lo, C. K., Stott, D. I. et al., Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15. Eur. J. Immunol. 2008. 38: 1664-1676.
43. Divekar, A. A., Dubey, S., Gangalum, P. R. and Singh, R. R., Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J. Immunol. 2011. 186: 924-930.
44. Iikuni, N., Lourenco, E. V., Hahn, B. H. and La Cava, A., Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol. 2009. 183: 1518-1522.
45. + Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Arthritis Rheum. 2008. 58: 1751-1761.
46. Koga, T., Mizui, M., Yoshida, N., Otomo, K., Lieberman, L. A., Crispin, J. C. and Tsokos, G. C., KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3(+) regulatory T cells in MRL/lpr mice. Autoimmunity 2014. 47: 445-450.
47. + regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum. 2005. 52: 1180-1184.
48. + regulatory T cells in patients with systemic lupus erythematosus. Adv. Exp. Med. Biol. 2007. 601: 113-119.
49. high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 2007. 178: 2579-2588.
50. Bonelli, M., Savitskaya, A., von Dalwigk, K., Steiner, C. W., Aletaha, D., Smolen, J. S. and Scheinecker, C., Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 2008. 20: 861-868.
51. Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D. et al., Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 2005. 175: 8392-8400.
52. Alvarado-Sanchez, B., Hernandez-Castro, B., Portales-Perez, D., Baranda, L., Layseca-Espinosa, E., Abud-Mendoza, C., Cubillas-Tejeda, A. C. et al., Regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 2006. 27: 110-118.
53. Vargas-Rojas, M. I., Crispin, J. C., Richaud-Patin, Y. and Alcocer-Varela, J., Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 2008. 17: 289-294.
54. Lin, S. C., Chen, K. H., Lin, C. H., Kuo, C. C., Ling, Q. D. and Chan, C. H., The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur. J. Clin. Invest. 2007. 37: 987-996.
55. -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 2008. 58: 2120-2130.
56. Chavele, K. M. and Ehrenstein, M. R., Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis. FEBS Lett. 2011. 585: 3603-3610.
57. Alunno, A., Bartoloni, E., Bistoni, O., Nocentini, G., Ronchetti, S., Caterbi, S., Valentini, V. et al., Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new. Clin. Dev. Immunol. 2012. 2012: 823085.
58. Solomou, E. E., Juang, Y. T., Gourley, M. F., Kammer, G. M. and Tsokos, G. C., Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 2001. 166: 4216-4222.
59. + T cells in patients with systemic lupus erythematosus. J. Immunol. 2009. 182: 1689-1695.
60. Koenen, H. J., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. and Joosten, I., Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008. 112: 2340-2352.
61. + T cells in patients with new-onset systemic lupus erythematosus. Ann. Rheum. Dis. 2008. 67: 1037-1040.
62. + cells in untreated new-onset lupus patients regulatory T cells? Arthritis Res. Ther. 2009. 11: R153.
63. + cells in SLE. Arthritis Res. Ther. 2010. 12: 101.
64. + FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. PLoS One 2012. 7: e34662.
65. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G. and Rudensky, A. Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005. 22: 329-341.
66. Hill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., Mathis, D. et al., Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007. 27: 786-800.
67. + regulatory T cells. PLoS One 2012. 7: e34547.
68. + human T regulatory cells during in vitro expansion. Blood 2012. 119: 2810-2818.
69. Maggi, L., Santarlasci, V., Capone, M., Peired, A., Frosali, F., Crome, S. Q., Querci, V. et al., CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 2010. 40: 2174-2181.
70. + T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011. 63: 2504-2515.
71. Afzali, B., Mitchell, P. J., Edozie, F. C., Povoleri, G. A., Dowson, S. E., Demandt, L., Walter, G. et al., CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur. J. Immunol. 2013. 43: 2043-2054.
72. + regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 2011. 186: 4388-4395.
73. + regulatory T cells in human autoimmune disease. Nat. Med. 2011. 17: 673-675.
74. Beriou, G., Costantino, C. M., Ashley, C. W., Yang, L., Kuchroo, V. K., Baecher-Allan, C. and Hafler, D. A., IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009. 113: 4240-4249.
75. MacLennan, I. C., Germinal centers. Annu. Rev. Immunol. 1994. 12: 117-139.
76. Crotty, S., Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011. 29: 621-663.
77. Diamond, B., Katz, J. B., Paul, E., Aranow, C., Lustgarten, D. and Scharff, M. D., The role of somatic mutation in the pathogenic anti-DNA response. Annu. Rev. Immunol. 1992. 10: 731-757.
78. Chung, Y., Tanaka, S., Chu, F., Nurieva, R. I., Martinez, G. J., Rawal, S., Wang, Y. H. et al., Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 2011. 17: 983-988.
79. Grammer, A. C., Slota, R., Fischer, R., Gur, H., Girschick, H., Yarboro, C., Illei, G. G. et al., Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Invest. 2003. 112: 1506-1520.
80. Cappione, A. 3rd, Anolik, J. H., Pugh-Bernard, A., Barnard, J., Dutcher, P., Silverman, G. and Sanz, I., Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 2005. 115: 3205-3216.
81. Terrier, B., Costedoat-Chalumeau, N., Garrido, M., Geri, G., Rosenzwajg, M., Musset, L., Klatzmann, D. et al., Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus. J. Rheumatol. 2012. 39: 1819-1828.
82. Ma, L., Zhao, P., Jiang, Z., Shan, Y. and Jiang, Y., Imbalance of different types of CD4 (+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 2013. 174: 345-355.
83. Dolff, S., Bijl, M., Huitema, M. G., Limburg, P. C., Kallenberg, C. G. and Abdulahad, W. H., Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. Clin. Immunol. 2011. 141: 197-204.
84. Altman, A., Theofilopoulos, A. N., Weiner, R., Katz, D. H. and Dixon, F. J., Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J. Exp. Med. 1981. 154: 791-808.
85. Wofsy, D., Murphy, E. D., Roths, J. B., Dauphinee, M. J., Kipper, S. B. and Talal, N., Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J. Exp. Med. 1981. 154: 1671-1680.
86. Linker-Israeli, M., Bakke, A. C., Kitridou, R. C., Gendler, S., Gillis, S. and Horwitz, D. A., Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 1983. 130: 2651-2655.
87. de Faucal, P., Godard, A., Peyrat, M. A., Moreau, J. F. and Soulillou, J. P., Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus. Ann. Immunol. (Paris) 1984. 135D: 161-172.
88. Alcocer-Varela, J. and Alarcon-Segovia, D., Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 1982. 69: 1388-1392.
89. Hayashi, T., Hasegawa, K. and Adachi, C., Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice. Int. J. Exp. Pathol. 2005. 86: 289-296.
90. Vallin, H., Blomberg, S., Alm, G. V., Cederblad, B. and Ronnblom, L., Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin. Exp. Immunol. 1999. 115: 196-202.
91. Vallin, H., Perers, A., Alm, G. V. and Ronnblom, L., Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 1999. 163: 6306-6313.
92. Ronnblom, L. and Alm, G. V., A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 2001. 194: F59-F63.
93. Lovgren, T., Eloranta, M. L., Bave, U., Alm, G. V. and Ronnblom, L., Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004. 50: 1861-1872.
94. + regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 2008. 58: 801-812.
95. + T cell-mediated suppression by dendritic cells. Science 2003. 299: 1033-1036.
96. Kimura, A. and Kishimoto, T., IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 2010. 40: 1830-1835.
97. Bacher, N., Raker, V., Hofmann, C., Graulich, E., Schwenk, M., Baumgrass, R., Bopp, T. et al., Interferon-alpha suppresses cAMP to disarm human regulatory T cells. Cancer Res. 2013. 73: 5647-5656.
98. Goodman, W. A., Young, A. B., McCormick, T. S., Cooper, K. D. and Levine, A. D., Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression. J. Immunol. 2011. 186: 3336-3345.
99. Linker-Israeli, M., Deans, R. J., Wallace, D. J., Prehn, J., Ozeri-Chen, T. and Klinenberg, J. R., Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 1991. 147: 117-123.
100. Grondal, G., Gunnarsson, I., Ronnelid, J., Rogberg, S., Klareskog, L. and Lundberg, I., Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin. Exp. Rheumatol. 2000. 18: 565-570.
101. Rowland, S. L., Riggs, J. M., Gilfillan, S., Bugatti, M., Vermi, W., Kolbeck, R., Unanue, E. R. et al., Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 2014. 211: 1977-1991.
102. Ohtsuka, K., Gray, J. D., Stimmler, M. M., Toro, B. and Horwitz, D. A., Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 1998. 160: 2539-2545.
103. + regulatory T cell activity in both humans and mice. J. Immunol. 2004. 172: 834-842.
104. + T cells is facilitated by CTLA-4 signaling. J. Immunol. 2006. 177: 2331-2339.
105. Okamoto, A., Fujio, K., Okamura, T. and Yamamoto, K., Regulatory T-cell-associated cytokines in systemic lupus erythematosus. J. Biomed. Biotechnol. 2011. 2011: 463412.
106. Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H. and Kronenberg, M., Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 2009. 10: 1178-1184.
107. + regulatory T cells controlled by the transcription factor Egr-2. Proc. Natl. Acad. Sci. USA 2009. 106: 13974-13979.
108. + T cells in an interleukin-10-dependent manner. Immunity 2011. 34: 554-565.
109. Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J. M., Jack, R. S. et al., Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011. 34: 566-578.
110. + T cells selectively kill B lymphocytes. Blood 2006. 107: 3925-3932.
111. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M. et al., Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009. 10: 1000-1007.
112. Wehrens, E. J., Prakken, B. J. and van Wijk, F., T cells out of control-impaired immune regulation in the inflamed joint. Nat. Rev. Rheumatol. 2013. 9: 34-42.
113. Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H. J., Waldmann, H., Huehn, J. et al., Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012. 36: 262-275.
114. Bailey-Bucktrout, S. L., Martinez-Llordella, M., Zhou, X., Anthony, B., Rosenthal, W., Luche, H., Fehling, H. J. et al., Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 2013. 39: 949-962.
115. Duarte, J. H., Zelenay, S., Bergman, M. L., Martins, A. C. and Demengeot, J., Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur. J. Immunol. 2009. 39: 948-955.
116. Crispin, J. C., Kyttaris, V., Juang, Y. T. and Tsokos, G. C., Systemic lupus erythematosus: new molecular targets. Ann. Rheum. Dis. 2007. 66(Suppl 3): iii65-iii69.
117. Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B. et al., Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008. 29: 44-56.
118. + T cells. J. Exp. Med. 2008. 205: 1381-1393.
119. + regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 2009. 106: 4793-4798.
120. + antigen-specific autoimmune effectors in vitro and in vivo. J. Immunol. 2008. 181: 3137-3147.
121. Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T. B., Oukka, M. et al., IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007. 448: 484-487.
122. Wong, C. K., Wong, P. T., Tam, L. S., Li, E. K., Chen, D. P. and Lam, C. W., Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J. Clin. Immunol. 2010. 30: 45-52.